Treatment with the diabetes drug exenatide was associated with a significant decrease in hyperglycemia in acute stroke patients, a new study shows. The research could offer clinicians an alternative ...

An ambitious, nationwide clinical trial led by UVA Health's Karen Johnston, MD, has provided doctors with long-needed insights into the importance of managing stroke patients' blood sugar after ...

Hyperglycaemia is a frequent finding in the acute phase of ischaemic stroke and constitutes an independent driver of poor neurological outcome. Elevations in blood glucose at presentation reflect both ...

Acute hyperglycemia is a sudden, severe onset of high blood sugar levels that requires medical attention. It can lead to serious complications such as kidney damage. Hyperglycemia is a common ...

Global stroke incidence and prevalence continue rising alongside high, underrecognized OSA prevalence and rapidly expanding diabetes burden, with substantial bidirectional comorbidity in type 2 ...

UVA Health's Karen Johnston, MD, the SHINE trial leader, was pleased to see the new insights into best practices for stroke care. “These data from the SHINE trial continue to inform the national ...